Review article
Rare breast tumors
Ilija Guteša
; Department of Surgical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Andrej Roth
; Department of Surgical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Ivan Milas
; Department of Surgical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Danko Velimir Vrdoljak
; Department of Surgical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Zvonimir Zore
; Department of Surgical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Mirko Gulan
; Department of Surgical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Mladen Stanec
; Department of Surgical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Abstract
Invasive breast cancer is a heterogeneous disease which occurs with diff erent clinical presentations, pathohistological characteristics and clinical course. Most common types are invasive ductal carcinoma not otherwise specified (IDC-NOS, 70-80%) and invasive lobular carcinoma (5 – 15%). Systemic therapy of breast carcinomas is mostly determined by their molecular classification, which is based on genetic research of NOS ductal breast cancer, without the inclusion of rare histological
types. Since some rare breast tumors have excellent prognosis despite unfavorable molecular characteristics, when deciding on the optimal treatment, both molecular and prognostic characteristics should be considered. Tumors of non-epithelial origin, such as sarcomas, lymphomas and phyllodes tumors also appear in breasts.
Keywords
rare breast carcinoma; molecular classification; prognosis; non-epithelial tumors
Hrčak ID:
199190
URI
Publication date:
29.12.2014.
Visits: 1.223 *